Simulations Plus, Inc. is the leading developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) and Physiologically-Based Pharmacokinetic (PBPK) modeling and simulation software for the pharmaceutical and biotechnology, generics, chemical, cosmetic, and food ingredient industries today. Our software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better projects decisions... sooner.
Founded in 1996, Simulations Plus employs over 60 employees and is publicly-traded on the NASDAQ stock exchange (ticker symbol = SLP).Our headquarters are based in Lancaster, California, with our pharmacometrics consulting team located in Buffalo, New York. Trusted distributors handle sales and scientific support in Asian territories. 19 of the top 20 pharmaceutical companies, plus numerous mid- and small-sized companies and all major regulatory agencies, license our modeling & simulation technology.
Current Team (6)Update
Board Members and Advisors (1)Update
|Sep 12, 2016||Business Wire - Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2016|
|Aug 25, 2016||Business Wire - Simulations Plus Releases PKPlus™ Version 1.0|
|Aug 1, 2016||Business Wire - Simulations Plus Releases ADMET Predictor|
|Aug 1, 2016||Business Wire - Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share|
|Jul 14, 2016||Business Wire - Simulations Plus Reports Third Quarter FY2016 Financial Results|
|Jul 8, 2016||Business Wire - Quarter 2016 Earnings Release and Conference Call|
|Jun 2, 2016||Business Wire - Simulations Plus to Present at LD Micro Invitational on June 7, 2016|
|Apr 22, 2016||Business Wire - Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share|
42505 10th Street West
Lancaster, California 93534-7059